Hospital's changeover of bed-med record system a hassle to implement but a resounding success
October 15th 2012A bedside medication verification system at Cook Children's Medical Center (CCMC) in Fort Worth, Texas, has resulted in a 97% rate of compliance with electronic scanning of medications and patients.
Screening for those at high risk for T2DM does not reduce mortality within 10 years, study finds
October 15th 2012Screening patients who are at high risk for diabetes does not reduce their all-cause, cardiovascular, or diabetes-related mortality within 10 years, according to a study published Oct. 4 in The Lancet
Social value of statins merits actions to broaden treatment, improve adherence, study finds
October 15th 2012New evidence suggests that statins generate large survival and health benefits at the population level and greater use of and adherence to statins should be encouraged, according to a study published in the October issue of Health Affairs.
Updated ACOG guidelines: Implants, IUDs are best defense for unintended teen pregnancies
October 11th 2012The best method to prevent unintended pregnancy in teenage girls is the use of intrauterine devices and contraceptive implants, according to the latest guidelines issued by the American College of Obstetricians and Gynecologists.
Study: Tranexamic acid reduces bleeding deaths, thrombotic events in all trauma patients
October 11th 2012Tranexamic acid can safely be used in all trauma patients, not just those who are the most severely injured, according to data analyses results published in the Sept. 11 issue of the British Medical Journal.
NASP to offer a unified voice for specialty pharmacy
October 10th 2012The National Association of Specialty Pharmacy (NASP), a new organization that focuses on specialty pharmacy, had its first event this week at the Academy of Managed Care Pharmacy Educational Conference in Cincinnati, Ohio, and it announced Michael A. Nameth, RPh, MBA, will serve as the interim executive director.
Generic antidepressant taken off the market
October 8th 2012After reviewing new data, FDA has concluded that Budeprion XL 300 mg (bupropion hydrochloride extended-release tablets), manufactured by Impax Laboratories, Inc., and marketed by Teva Pharmaceuticals USA, Inc., is not therapeutically equivalent to GlaxoSmithKline’s Wellbutrin XL 300 mg.
Illinois appeals court upholds pharmacists right to refuse to dispense emergency contraception
October 8th 2012An Illinois appeals court recently upheld a ruling that pharmacists are permitted to refrain from prescribing emergency contraceptives, finding that healthcare professionals are protected by an Illinois state law.
FDA gives green light to ANDA for chewable diabetes tablet
October 8th 2012FDA has approved Boston Therapeutic’s petition to file an Abbreviated New Drug Application (ANDA) for a new, chewable tablet formulation of the diabetes drug metformin hydrochloride. The company plans to market the new formulation under the name Pazamet.